The U.S. Food and Drug Administration said on Tuesday it had named Scott Steele as acting director of its Center for Biologics Evaluation and Research (CBER), following the exit of top vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback